CURX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Curanex Pharmaceuticals Inc (CURX) is not a good buy for a beginner investor with a long-term strategy at this time. The stock shows a bearish technical trend, no significant trading sentiment, no recent news or catalysts, and weak financial performance. Given the lack of positive signals and the investor's preference for long-term growth, it is better to hold off on investing in this stock.
The technical indicators are bearish. The MACD is negatively expanding, RSI is neutral at 31.865, and moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels (S1: 0.269) with no signs of reversal.
NULL. There are no recent news updates, no significant insider or hedge fund activity, and no recent congress trading data.
Bearish technical indicators, weak financial performance, and no significant trading or news catalysts. The stock is also underperforming relative to the broader market (S&P 500 down -1.54%).
In Q3 2025, the company reported zero revenue growth (0.00% YoY), a net income of -$954,059 (up 946.51% YoY due to prior losses), and an EPS of -0.04. Gross margin remains at 0. These metrics indicate poor financial health and no signs of growth.
No analyst rating or price target data available.
